Pneumomediastinum and pneumoretroperitoneum after COVID-19: concealed intestinal perforation.
Air leakage
COVID-19
Intestinal perforation
Pneumomediastinum
Pneumoretroperitoneum
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
08 Aug 2024
08 Aug 2024
Historique:
received:
13
02
2024
accepted:
05
08
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
8
8
2024
Statut:
epublish
Résumé
With the prevalence of coronavirus disease 2019 (COVID-19), many severe cases have been discovered worldwide. Here, a case of concurrent pneumomediastinum, pneumoretroperitoneum, and intestinal perforation was reported. This case was the first report on COVID-19-induced related complications. A 74-year-old female patient was hospitalized for COVID-19. Air leakage was unexpectedly found during imaging reexamination. Considering the unobvious subjective feeling of the patient, a conservative treatment was given at the early stage, and finally, sigmoid colon perforation was surgically confirmed. The family gave up the treatment at last, because the patient could not be taken off the ventilator. Coincidentally, the patient also had abnormal renal anatomical position. This situation led to an abnormal air leakage direction and the atypical manifestations of peritonitis. It was also one of the important reasons for the delayed diagnosis and treatment of the disease. Clinicians should be vigilant for spontaneous gastrointestinal perforation in patients with COVID-19, particularly those undergoing treatment with glucocorticoids and tocilizumab. The case is shared to highlight this rare and fatal extrapulmonary manifestation of COVID-19 and further assist clinicians to raise their awareness and timely implement imaging investigation and multidisciplinary intervention so as to facilitate early discovery, diagnosis and treatment and reduce the mortality.
Sections du résumé
BACKGROUND
BACKGROUND
With the prevalence of coronavirus disease 2019 (COVID-19), many severe cases have been discovered worldwide. Here, a case of concurrent pneumomediastinum, pneumoretroperitoneum, and intestinal perforation was reported. This case was the first report on COVID-19-induced related complications.
CASE PRESENTATION
METHODS
A 74-year-old female patient was hospitalized for COVID-19. Air leakage was unexpectedly found during imaging reexamination. Considering the unobvious subjective feeling of the patient, a conservative treatment was given at the early stage, and finally, sigmoid colon perforation was surgically confirmed. The family gave up the treatment at last, because the patient could not be taken off the ventilator. Coincidentally, the patient also had abnormal renal anatomical position. This situation led to an abnormal air leakage direction and the atypical manifestations of peritonitis. It was also one of the important reasons for the delayed diagnosis and treatment of the disease.
CONCLUSIONS
CONCLUSIONS
Clinicians should be vigilant for spontaneous gastrointestinal perforation in patients with COVID-19, particularly those undergoing treatment with glucocorticoids and tocilizumab. The case is shared to highlight this rare and fatal extrapulmonary manifestation of COVID-19 and further assist clinicians to raise their awareness and timely implement imaging investigation and multidisciplinary intervention so as to facilitate early discovery, diagnosis and treatment and reduce the mortality.
Identifiants
pubmed: 39118012
doi: 10.1186/s12879-024-09720-3
pii: 10.1186/s12879-024-09720-3
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
801Informations de copyright
© 2024. The Author(s).
Références
Parotto M, Gyöngyösi M, Howe K, Myatra SN, Ranzani O, Shankar-Hari M, et al. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med. 2023;11(8):739–54.
doi: 10.1016/S2213-2600(23)00239-4
pubmed: 37475125
Abobaker A, Raba AA, Alzwi A. Extrapulmonary and atypical clinical presentations of COVID-19. J Med Virol. 2020;92(11):2458–64.
doi: 10.1002/jmv.26157
pubmed: 32520401
pmcid: 7300507
Khan HH, Witkowski A, Clark JA, Mata A. A 17-Year-old girl with a recent history of Marijuana Use presented with Pneumomediastinum and Pneumopericardium and tested positive for SARS-CoV-2 infection on Hospital Admission. Am J Case Rep. 2021;22:e931800.
doi: 10.12659/AJCR.931800
pubmed: 34131098
pmcid: 8216567
Ahmed AOE, Mohamed MFH, Ahmed K, Severe. COVID-19 Pneumonia complicated by Pneumothorax, Pneumomediastinum, and Pneumoperitoneum. Am J Trop Med Hyg. 2021;104(6):1951–2.
doi: 10.4269/ajtmh.21-0092
pubmed: 33819176
pmcid: 8176475
Vetter P, Vu DL, L’Huillier AG, Schibler M, Kaiser L, Jacquerioz F. Clinical features of covid-19. BMJ. 2020;369:m1470.
doi: 10.1136/bmj.m1470
pubmed: 32303495
Nasa P, Juneja D, Jain R. Air leak with COVID-19 - a meta-summary. Asian Cardiovasc Thorac Ann. 2022;30(2):237–44.
doi: 10.1177/02184923211031134
pubmed: 34247490
pmcid: 8990622
Belletti A, Pallanch O, Bonizzoni MA, Guidi L, De Cobelli F, Landoni G, et al. Clinical use of Macklin-like radiological sign (Macklin effect): a systematic review. Respir Med. 2023;210:107178.
doi: 10.1016/j.rmed.2023.107178
pubmed: 36863617
Elabbadi A, Urbina T, Berti E, Contou D, Plantefève G, Soulier Q, et al. Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients. Crit Care. 2022;26(1):350.
doi: 10.1186/s13054-022-04228-1
pubmed: 36371306
pmcid: 9652578
Paternoster G, Belmonte G, Scarano E, Rotondo P, Palumbo D, Belletti A, et al. Macklin effect on baseline chest CT scan accurately predicts barotrauma in COVID-19 patients. Respir Med. 2022;197:106853.
doi: 10.1016/j.rmed.2022.106853
pubmed: 35512457
pmcid: 9020841
Brito J, Gregório P, Mariani A, D’ambrosio P, Filho M, Ferreira L, et al. Pneumomediastinum in COVID-19 disease: outcomes and relation to the Macklin effect. Asian Cardiovasc Thorac Ann. 2021;29(6):541–8.
doi: 10.1177/02184923211010089
pubmed: 33853387
Battaglini D, Robba C, Ball L, Silva PL, Cruz FF, Pelosi P, et al. Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review. Br J Anaesth. 2021;127:353–64.
doi: 10.1016/j.bja.2021.05.024
pubmed: 34217468
Machiraju PK, Alex NM, Safinaaz, Baby NM. Pneumomediastinum in COVID-19: a series of three cases and review of literature. SAGE Open Med Case Rep. 2021;9:2050313X211011807.
pubmed: 34017591
pmcid: 8114250
Sharma M, Ojha P, ,Taweesedt PT, ,Ratnani I, ,Surani SA. Intriguing case of Pneumoperitoneum in a patient with COVID-19: do all Pneumoperitoneum cases need. Surgery? Cureus. 2020;12(12):e12279.
pubmed: 33510986
Kulinna-Cosentini C, Hodge JC, Ba-Ssalamah A. The role of radiology in diagnosing gastrointestinal tract perforation. Best Pract Res Clin Gastroenterol. 2024;70:101928.
doi: 10.1016/j.bpg.2024.101928
pubmed: 39053981
Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until Discharge. Gastroenterology. 2020;159(4):1302–10.
doi: 10.1053/j.gastro.2020.06.048
pubmed: 32598884
Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis. 2020;71(10):2669–78.
doi: 10.1093/cid/ciaa709
pubmed: 32497191
Banerjee S, Singh SK, Thakur SD, Pneumomediastinum. Tension Pneumoperitoneum secondary to Bowel Perforation in Post COVID-19 patient: a Case Report. Ann Clin Case Rep. 2021;6:1915.
Ancona G, Alagna L, Alteri C, Palomba E, Tonizzo A, Pastena A, et al. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front Immunol. 2023;14:1080043.
doi: 10.3389/fimmu.2023.1080043
pubmed: 36969243
pmcid: 10030519
Domingo P, Mur I, Pomar V, Corominas H, Casademont J, de Benito N. The four horsemen of a viral Apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19). EBioMedicine. 2020;58:102887.
doi: 10.1016/j.ebiom.2020.102887
pubmed: 32736307
pmcid: 7387269
Hashim Z, Khan A, Areekkara P. Thrombosis leading to acute abdomen in corona virus disease- 19:a case series. Indian J Gastroenterol. 2022;41(3):313–8.
doi: 10.1007/s12664-022-01260-5
pubmed: 35907170
pmcid: 9362381
Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020;69(12):1181–9.
doi: 10.1007/s00011-020-01401-6
pubmed: 32918567
pmcid: 7486586
Rojo M, Cano-Valderrama O, Picazo S, Saez C, Gómez L, Sánchez C, et al. Gastrointestinal perforation after treatment with tocilizumab: an unexpected consequence of COVID-19 pandemic. Am Surg. 2020;86(6):565–6.
doi: 10.1177/0003134820926481
pubmed: 32683974
Vikse J, Henry BM. Tocilizumab in COVID-19: beware the risk of intestinal perforation. Int J Antimicrob Agents. 2020;56(1):106009.
doi: 10.1016/j.ijantimicag.2020.106009
pubmed: 32389721
pmcid: 7204657
Xie F, Yun H, Bernatsky S, Curtis JR, Brief, Report. Risk of gastrointestinal perforation among rheumatoid arthritis patients receiving Tofacitinib, Tocilizumab, or other Biologic treatments. Arthritis Rheumatol. 2016;68(11):2612–7.
doi: 10.1002/art.39761
pubmed: 27213279
pmcid: 5538140